Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics-Reference-Cited by-同舟云学术

Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnostics

Published:2020-01-30 Issue:2 Volume:19 Page:161-167
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Morak Monika^ORCID,Steinke-Lange Verena^ORCID,Massdorf Trisari,Benet-Pages Anna,Locher Melanie,Laner Andreas^ORCID,Kayser Katrin,Aretz Stefan^ORCID,Holinski-Feder Elke

Funder

Wilhelm Sander-Stiftung

Deutsche Krebshilfe

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics(clinical),Oncology,Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10689-020-00159-4.pdf

Reference35 articles.

1. Lynch HT, de la Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36(11):801–818

2. Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH, Kim YS (2004) BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:191–195

3. Pearlman R, Haraldsdottir S, de la Chapelle A, Jonasson JG, Liyanarachchi S, Frankel WL, Rafnar T, Stefansson K, Pritchard CC, Hampel H (2019) Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome. J Med Genet 56(7):462–470. https://doi.org/10.1136/jmedgenet-2018-105698

4. Vargas-Parra GM, Gonzalez-Acosta M, Thompson BA, Gomez C, Fernandez A, Damaso E, Pons T, Morak M, Del Valle J, Iglesias S, Velasco A, Solanes A, Sanjuan X, Padilla N, de la Cruz X, Valencia A, Holinski-Feder E, Brunet J, Feliubadalo L, Lazaro C, Navarro M, Pineda M, Capella G (2017) Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis. Int J Cancer 141(7):1365–1380. https://doi.org/10.1002/ijc.30820

5. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of inversions across 33,924 families with rare disease from a national genome sequencing project;The American Journal of Human Genetics;2024-06

2. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome;Journal of Translational Medicine;2023-04-26

3. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome;2023-03-01

4. Genome sequencing identifies complex structural MLH1 variant in unsolved Lynch syndrome;Molecular Genetics & Genomic Medicine;2023-02-09

5. Detecting inversions in routine molecular diagnosis in MMR genes;Familial Cancer;2022-01-08